Sydney International Conference, ‘Advancing Multi-Omics into the Clinic’. Through this two-day meeting, internationally renowned experts in proteomics, genomics, cancer management, biomarker and drug discovery will share their progress towards addressing the challenges and opportunities of multi-omic data integration in cancer management, with a special focus on the role of proteomics in advancing biomarker development and drug discovery.

Multi-omics, leveraged by cutting-edge technological breakthroughs, are revolutionizing how we understand disease biology. The field of multi-omics has exploded over the last few years with applications spanning cancer, infectious disease and immunology.

Over 3 days, this meeting will deliver forward-thinking perspectives on the latest in multi-omics, including Spatial Biology, Digital Pathology, Artificial-intelligence, and Omics-based deep tissue and liquid biopsy profiling.

The vision of the Multi-omics 2024 meeting is to bring together the critical mass of Multi-omics researchers both nationally, and internationally, with exciting sessions in immuno-oncology, infectious disease and immunology. The meeting will feature experimental design, methodologies, and analytical pipelines including bioinformatics, computational biology and pathology. This will be supported by multiple technology companies, platform launches, technical workshops and real-world datasets.